Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email | Twitter) and we will feature it here at the end of each week.
Endo appoints former Bausch + Lomb exec to head corporate strategy
Endo ($ENDP) appointed Dr. Hemanth Varghese as executive vice president of corporate development and strategy. Most recently, Varghese served as the senior vice president and general manager of vision care for Bausch + Lomb, a division of Valeant Pharmaceuticals ($VRX). Release
|
||||||||||||
Biotech
> Former head of Roche Oncology ($RHHBY) Dr. Kapil Dhingra has joined Advanced Accelerator Applications' board of directors as an independent nonexecutive director. Release
> Intercept Pharmaceuticals ($ICPT) has appointed Rachel McMinn to the newly created position of chief strategy officer. Release
> Regado Biosciences ($RGDO) appointed R. Don Elsey as senior vice president of finance and chief financial officer. Release
> Omni Bio Pharmaceutical appointed Dr. Bruce Forrest to the position of chief development officer. Release
> Prothena ($PRTA) appointed Arthur "Bill" Homan as chief legal officer. Release
> Niklas Savander is assuming the role of president and CEO of Elekta, succeeding Tomas Puusepp, who will continue as a member of the company's board of directors. Release
> Tauriga Sciences appointed Dr. Lawrence May as its chief medical officer. Release
> Guillaume Jetten resigned as CFO of Galapagos, and Laure Verhaegen will act as interim CFO. Release
> Coherus Biosciences appointed Michael Fleming as its senior vice president of commercial strategy. Release
> MacroGenics ($MGNX) appointed Atul Saran as senior vice president and general counsel. Release
> Molecular biologist and virologist Marco Kaiser joined ImmunoClin's scientific advisory board. Release
> Actinium announced that Dr. David Gould joined the company as senior vice president of finance and corporate development, Dennis Earle as senior vice president of clinical operations, Gerald Orehostky as vice president of quality and regulatory affairs and Evan Smith as vice president of investor relations and finance. Release
> Recipharm appointed Henning Neubauer and Antonio Lopez to its business management team as business director for North Germany and the Netherlands and chief operating officer, respectively. Release
CRO
> INC Research appointed Jonathan Shough as its chief information officer. Release
Medical Devices
> Noxilizer brought on Robert Contino as its director of U.S. customer and technical service. Release
> CardioDx appointed Melinda Griffith as the head of its corporate development and general counsel and Dr. Doug Ross as its chief scientific officer. Story